# Lifen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lifen

- Industry: Healthcare IT
- Headquarters: Paris, France
- Website: www.lifen.fr
- Total disclosed funding: $79M
- Latest round: Series C (Jan 20, 2022)
- Investors on record: 10

## About

Lifen is a healthcare technology company providing advanced data intelligence solutions to improve patient care through innovative document management and integration services.Founded in 2015 in Paris, France, Lifen focuses on leveraging data intelligence for healthcare professionals. The company has engaged in 4 funding deals, with the most recent funding round occurring on January 20, 2022, where it raised EUR 40.28 mn in Series C funding, primarily from Creadev and Lauxera Capital Partners. Lifen is co-founded by Alexandre Huckert, Etienne Depaulis, and Franck Le Ouay, who also serves as the CEO. The company currently has an estimated valuation of EUR 211.067 mn.Lifen specializes in providing innovative data intelligence solutions tailored for healthcare professionals, including private practitioners and hospitals. Its core offerings encompass Lifen Documents for sharing medical records, Lifen Integration for automating document structuring into Digital Patient Records, and Lifen DataLab, which accelerates clinical research through AI. Trusted by over 800 healthcare establishments across France, Lifen's solutions aim to streamline patient care and enhance decision-making through intelligent data management.Lifen operates on a subscription-based revenue model, with clients such as hospitals and private clinics subscribing for access to its services, including Lifen Documents and Lifen Integration. In the most recent fiscal year, Lifen reported revenues of EUR 14,391, with an EBITDA of EUR -1,933,035.70.In January 2022, Lifen raised EUR 40.28 mn in Series C funding to scale its eHealth infrastructure and expand its workforce. The company aims to launch new products to further enhance its offerings and is actively seeking to penetrate additional geographic markets. Specific target markets for expansion have not been disclosed, but the funding will support these initiatives as Lifen continues to enhance its impact on the healthcare sector.

## Funding rounds

- Series C, Jan 20, 2022, $45M — Partech Partners, Serena, Creadev, MACSF, Lauxera Capital Partners
- Series B, Sep 4, 2020, $24M — Idinvest Partners, Partech Partners, Serena, Daphni, Mayjcc eSanté Invest
- Series A, Mar 2, 2018, $9.2M — Serena, RTA Ventures, Daphni, Tomcat Invest

## Investors

- Serena (https://capitalatlas.ai/funds/serena) — Series A, Series B, Series C
- RTA Ventures (https://capitalatlas.ai/funds/rta-ventures) — Series A
- Daphni (https://capitalatlas.ai/funds/daphni) — Series A, Series B
- Tomcat Invest (https://capitalatlas.ai/funds/tomcat-invest) — Series A
- Idinvest Partners (https://capitalatlas.ai/funds/idinvest-partners) — Series B
- Partech Partners (https://capitalatlas.ai/funds/partech-partners) — Series B, Series C
- Mayjcc eSanté Invest — Series B
- Creadev — Series C
- MACSF — Series C
- Lauxera Capital Partners (https://capitalatlas.ai/funds/lauxera-capital-partners) — Series C